Tekla Healthcare Return On Equity vs. Revenue
| HQH Stock | USD 17.43 0.03 0.17% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter 0.0696 | Current Value 0.0754 | Quarterly Volatility 0.15497738 |
For Tekla Healthcare profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Tekla Healthcare to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Tekla Healthcare Investors utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Tekla Healthcare's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Tekla Healthcare Investors over time as well as its relative position and ranking within its peers.
Tekla |
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Healthcare. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.145 | Dividend Share 1.66 | Earnings Share 1.31 | Revenue Per Share 0.197 | Quarterly Revenue Growth (0.06) |
The market value of Tekla Healthcare Inv is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tekla Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Healthcare's market value can be influenced by many factors that don't directly affect Tekla Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Tekla Healthcare Inv Revenue vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Tekla Healthcare's current stock value. Our valuation model uses many indicators to compare Tekla Healthcare value to that of its competitors to determine the firm's financial worth. Tekla Healthcare Investors is one of the top stocks in return on equity category among its peers. It also is rated as one of the top companies in revenue category among its peers totaling about 791,802,098 of Revenue per Return On Equity. As of now, Tekla Healthcare's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tekla Healthcare's earnings, one of the primary drivers of an investment's value.Tekla Revenue vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Tekla Healthcare |
| = | 0.0734 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Tekla Healthcare |
| = | 58.12 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Tekla Revenue vs Competition
Tekla Healthcare Investors is rated as one of the top companies in revenue category among its peers. Market size based on revenue of Financials industry is currently estimated at about 395.53 Million. Tekla Healthcare retains roughly 58.12 Million in revenue claiming about 15% of equities under Financials industry.
Tekla Healthcare Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Tekla Healthcare, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Tekla Healthcare will eventually generate negative long term returns. The profitability progress is the general direction of Tekla Healthcare's change in net profit over the period of time. It can combine multiple indicators of Tekla Healthcare, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | 64.8 M | 68 M | |
| Income Before Tax | 64.8 M | 48.6 M | |
| Total Other Income Expense Net | -3.6 K | -3.4 K | |
| Net Income | 64.8 M | 48.6 M | |
| Net Income From Continuing Ops | 50.7 M | 37.1 M | |
| Net Loss | -174.8 M | -166.1 M | |
| Income Tax Expense | -1.1 M | -1.1 M | |
| Interest Income | 558 K | 530.1 K | |
| Net Interest Income | 713 K | 748.7 K | |
| Change To Netincome | -326.9 M | -310.6 M | |
| Net Income Per Share | 1.31 | 2.42 | |
| Income Quality | (0.73) | (0.69) | |
| Net Income Per E B T | 0.90 | 0.80 |
Tekla Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Tekla Healthcare. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Tekla Healthcare position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Tekla Healthcare's important profitability drivers and their relationship over time.
Use Tekla Healthcare in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tekla Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tekla Healthcare will appreciate offsetting losses from the drop in the long position's value.Tekla Healthcare Pair Trading
Tekla Healthcare Investors Pair Trading Analysis
The ability to find closely correlated positions to Tekla Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tekla Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tekla Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tekla Healthcare Investors to buy it.
The correlation of Tekla Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tekla Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tekla Healthcare Inv moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tekla Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Tekla Healthcare position
In addition to having Tekla Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Precious Metals ETFs Thematic Idea Now
Precious Metals ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Precious Metals ETFs theme has 28 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Precious Metals ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
To fully project Tekla Healthcare's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Tekla Healthcare Inv at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Tekla Healthcare's income statement, its balance sheet, and the statement of cash flows.